SCHEMBL19780270

SCHEMBL19780270

CCCC(C)c1nccc(C=N)c1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20621309 0.88 — —
SCHEMBL19779245 0.80 NOS3 (0.31) —
SCHEMBL20621277 0.76 NOS2 (0.33) —
SCHEMBL24574394 0.73 USP2 (0.30) —
SCHEMBL19779999 0.73 ALDH1A1 (0.34) —
SCHEMBL22096909 0.70 NOS2 (0.36) —
SCHEMBL25887311 0.70 HTR2A (0.36) —
SCHEMBL21883622 0.69 NOS2 (0.43) —
SCHEMBL19880512 0.69 — —
SCHEMBL21884029 0.68 NOS2 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171492-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2021-06-10 — — US disclosed
US-10597377-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-24 — — US disclosed
US-20180016252-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2018-01-18 — — US disclosed
Send feedback